American Portfolios Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

American Portfolios Advisors’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-40	Closed	-$212	–	3559
2021 Q2	$212	Buy	+40	New	+$192	﹤0.01%	3358
2020 Q3	–	Sell	-428	Closed	-$1.44K	–	3003
2020 Q2	$1.44K	Hold	428	–	–	﹤0.01%	2620
2020 Q1	$1.64K	Hold	428	–	–	﹤0.01%	2455
2019 Q4	$2.58K	Hold	428	–	–	﹤0.01%	2504
2019 Q3	$3.24K	Sell	428 -149	-26%	-$1.68K	﹤0.01%	2348
2019 Q2	$7.82K	Buy	577 +149	+35%	+$1.72K	﹤0.01%	1995
2019 Q1	$2.32K	Hold	428	–	–	﹤0.01%	2336
2018 Q4	$1.27K	Buy	+428	New	+$2.34K	﹤0.01%	2225
2018 Q3	–	Sell	-215	Closed	-$2.09K	–	2501
2018 Q2	$2.09K	Hold	215	–	–	﹤0.01%	2189
2018 Q1	$1.87K	Buy	+215	New	+$2.32K	﹤0.01%	2113

Other funds holding ZYNE

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

American Portfolios Advisors's ZYNE Position: Q3 2021 in Review

American Portfolios Advisors sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q3 2021, closing a stake of 40 shares — an estimated $212 sold.

American Portfolios Advisors first reported a position in ZYNE in Q1 2018 and held it in 10 quarters. The position peaked at $7.82K in Q2 2019. 58 funds tracked by Wall St. Rank hold ZYNE as of Q3 2021.

American Portfolios Advisors reported no remaining Zynerba Pharmaceuticals, Inc position as of Q3 2021 after selling out during the quarter.
American Portfolios Advisors sold 40 Zynerba Pharmaceuticals, Inc shares in Q3 2021, an estimated $212.
American Portfolios Advisors first reported a position in Zynerba Pharmaceuticals, Inc in Q1 2018 and held it in 10 quarters.
American Portfolios Advisors's Zynerba Pharmaceuticals, Inc position peaked at $7.82K in Q2 2019.
58 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q3 2021.

Based on American Portfolios Advisors's 13F filing for Q3 2021, filed 22 Mar 2023.